Play all audios:
_Nature Reviews Immunology_ 11, 658–671 (2011) In the original version of this article, in the section under the subheading “CNS-specific NK cells in disease” on page 668, the humanized
antibody daclizumab was incorrectly described as being specific for the IL-2 receptor β-chain (CD122). The corrected sentence now reads: “These findings might be relevant to the mode of
action of daclizumab, a humanized antibody specific for the IL-2 receptor α-chain (CD25)”. The authors apologize for this error. Authors * Fu-Dong Shi View author publications You can also
search for this author inPubMed Google Scholar * Hans-Gustaf Ljunggren View author publications You can also search for this author inPubMed Google Scholar * Antonio La Cava View author
publications You can also search for this author inPubMed Google Scholar * Luc Van Kaer View author publications You can also search for this author inPubMed Google Scholar ADDITIONAL
INFORMATION The online version of the original article can be found at 10.1038/nri3065 RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Shi, FD.,
Ljunggren, HG., La Cava, A. _et al._ Erratum: Organ-specific features of natural killer cells. _Nat Rev Immunol_ 11, 880 (2011). https://doi.org/10.1038/nri3116 Download citation *
Published: 18 November 2011 * Issue Date: December 2011 * DOI: https://doi.org/10.1038/nri3116 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content:
Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative